Polygenic risk score identifies associations between sleep duration and diseases determined from an electronic medical record biobank

Sleep

Volumn 42, Issue 3, 2019, Pages

  Dashti, Hassan S ^a,b   Redline, Susan ^c   Saxena, Richa ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cardiometabolic diseases; epidemiology; polygenic risk score; psychiatric disorders; sleep duration

Indexed keywords

ADULT; ARTICLE; ASTHMA; BIOBANK; CAUSALITY; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASES; ELECTRONIC MEDICAL RECORD; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTIFACTORIAL INHERITANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SLEEP DISORDERED BREATHING; SLEEP TIME; ELECTRONIC HEALTH RECORD; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROCEDURES; SLEEP;

BIOLOGICAL SPECIMEN BANKS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORDS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; OBESITY; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 85063726048     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/zsy247     Document Type: Article

References (55)

1. Lane JM, et al. Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits. Nat Genet. 2017; 49(2): 274-281.
2. Watson NF, et al. Recommended amount of sleep for a healthy adult: A joint consensus statement of the American academy of sleep medicine and sleep research society. Sleep. 2015; 38(6): 843-844.
3. Ayas NT, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003; 26(2): 380-384.
4. Ayas NT, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003; 163(2): 205-209.
5. Kripke DF, et al. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002; 59(2): 131-136.
6. Kronholm E, et al. Trends in self-reported sleep duration and insomnia-related symptoms in Finland from 1972 to 2005: A comparative review and re-Analysis of Finnish population samples. J Sleep Res. 2008; 17(1): 54-62.
7. Qureshi AI, et al. Habitual sleep patterns and risk for stroke and coronary heart disease: A 10-year follow-up from NHANES I. Neurology. 1997; 48(4): 904-911.
8. Wingard DL, et al. Mortality risk associated with sleeping patterns among adults. Sleep. 1983; 6(2): 102-107.
9. Cappuccio FP, et al. Sleep duration and all-cause mortality: A systematic review and meta-Analysis of prospective studies. Sleep. 2010; 33(5): 585-592.
10. Cappuccio FP, et al. Sleep duration predicts cardiovascular outcomes: A systematic review and meta-Analysis of prospective studies. Eur Heart J. 2011; 32(12): 1484-1492.
11. Cappuccio FP, et al. Meta-Analysis of short sleep duration and obesity in children and adults. Sleep. 2008; 31(5): 619-626.
12. Cappuccio FP, et al. Quantity and quality of sleep and incidence of type 2 diabetes: A systematic review and metaanalysis. Diabetes Care. 2010; 33(2): 414-420.
13. Karlson E, et al. Building the partners healthcare biobank at partners personalized medicine: Informed consent, return of research results, recruitment lessons and operational considerations. J Pers Med. 2016; 6(1): 2.
14. Gottesman O, et al.; eMERGE Network. The electronic medical records and genomics (eMERGE) network: Past, present, and future. Genet Med. 2013; 15(10): 761-771.
15. Denny JC, et al. Systematic comparison of phenomewide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol. 2013; 31(12): 1102-1110.
16. Verma A, et al. PheWAS and beyond: The landscape of associations with medical diagnoses and clinical measures across 38,662 individuals from Geisinger. Am J Hum Genet. 2018; 102(4). doi: 10.1016/j.ajhg.2018.02.017
17. Lewis CM, et al. Prospects for using risk scores in polygenic medicine. Genome Med. 2017; 9(1): 96.
18. Solovieff N, et al. Pleiotropy in complex traits: Challenges and strategies. Nat Rev Genet. 2013; 14(7): 483-495.
19. Purcell SM, et al.; International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009; 460(7256): 748-752.
20. Knowles JW, et al. Cardiovascular disease: The rise of the genetic risk score. PLoS Med. 2018; 15(3): E1002546.
21. Khera AV, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018; 50(9): 1219-1224.
22. de Castro JM. The influence of heredity on self-reported sleep patterns in free-living humans. Physiol Behav. 2002; 76(4-5): 479-486.
23. Dashti H, et al. GWAS in 446,118 European adults identifies 78 genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates. bioRxiv. 2018. http://biorxiv.org/content/early/2018/04/19/274977. abstract
24. Smoller JW, et al. An eMERGE clinical center at partners personalized medicine. J Pers Med. 2016; 6(1): 5.
25. Das S, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016; 48(10): 1284-1287.
26. McCarthy S, et al.; Haplotype Reference Consortium. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016; 48(10): 1279-1283.
27. O'Connell J, et al. A general approach for haplotype phasing across the full spectrum of relatedness. PLoS Genet. 2014; 10(4): E1004234.
28. Wang C, et al. Improved ancestry estimation for both genotyping and sequencing data using projection procrustes analysis and genotype imputation. Am J Hum Genet. 2015; 96(6): 926-937.
29. Cann HM, et al. A human genome diversity cell line panel. Science. 2002; 296(5566): 261-262.
30. Euesden J, et al. PRSice: Polygenic risk score software. Bioinformatics. 2015; 31(9): 1466-1468.
31. Jones SE, et al. Genome-wide association analyses in 128,266 individuals identifies new morningness and sleep duration loci. Shi J, ed. PLoS Genet. 2016; 12(8): E1006125.
32. Lawlor DA. Commentary: Two-sample Mendelian randomization: Opportunities and challenges. Int J Epidemiol. 2016; 45(3): 908-915.
33. Burgess S, et al. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7): 658-665.
34. Bowden J, et al. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015; 44(2): 512-525.
35. Bowden J, et al. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016; 40(4): 304-314.
36. Singh M, et al. The association between obesity and short sleep duration: A population-based study. J Clin Sleep Med. 2005; 1(4): 357-363.
37. Devinsky O, et al. Epilepsy and sleep apnea syndrome. Neurology. 1994; 44(11): 2060-2064.
38. Cappuccio FP, et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension: The Whitehall II Study. Hypertension. 2007; 50(4): 693-700.
39. Li W, et al. Sleep duration and risk of stroke events and stroke mortality: A systematic review and metaanalysis of prospective cohort studies. Int J Cardiol. 2016; 223: 870-876.
40. Perlman CA, et al. The prospective impact of sleep duration on depression and mania. Bipolar Disord. 2006; 8(3): 271-274.
41. Gottlieb DJ, et al. Novel loci associated with usual sleep duration: The CHARGE consortium genome-wide association study. Mol Psychiatry. 2015; 20(10): 1232-1239.
42. Cade BE, et al. Common variants in DRD2 are associated with sleep duration: The CARe consortium. Hum Mol Genet. 2016; 25(1): 167-179.
43. Gottlieb DJ, et al. Genome-wide association of sleep and circadian phenotypes. BMC Med Genet. 2007; 8(Suppl 1): S9.
44. Lane JM, et al. Biological and clinical insights from genetics of insomnia symptoms. bioRxiv. 2018. http://biorxiv.org/content/early/2018/02/02/257956.abstract
45. Vgontzas AN, et al. Insomnia with objective short sleep duration: The most biologically severe phenotype of the disorder. Sleep Med Rev. 2013; 17(4): 241-254.
46. Laugsand LE, et al. Insomnia and the risk of incident heart failure: A population study. Eur Heart J. 2014; 35(21): 1382-1393.
47. DiBona GF. Sympathetic nervous system and hypertension. Hypertens (Dallas, Tex 1979). 2013; 61(3): 556-560.
48. Nagai M, et al. Sleep duration as a risk factor for cardiovascular disease-A review of the recent literature. Curr Cardiol Rev. 2010; 6(1): 54-61.
49. O'Malley KJ, et al. Measuring diagnoses: ICD code accuracy. Health Serv Res. 2005; 40(5 Pt 2): 1620-1639.
50. Verma A, et al. A simulation study investigating power estimates in phenome-wide association studies. BMC Bioinf. 2018; 19(1): 120.
51. Holliday EG, et al. Short sleep duration is associated with risk of future diabetes but not cardiovascular disease: A prospective study and meta-Analysis. Arias-Carrion O, ed. PLoS One. 2013; 8(11): E82305.
52. Bianchi MT, et al. An open request to epidemiologists: Please stop querying self-reported sleep duration. Sleep Med. 2017; 35: 92-93.
53. Jones SE, et al. Genetic studies of accelerometer-based sleep measures in 85,670 individuals yield new insights into human sleep behaviour. bioRxiv. 2018. http://biorxiv.org/content/early/2018/09/13/303925.abstract
54. Li X, et al. MR-PheWAS: Exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank. Ann Rheum Dis. 2018. doi: 10.1136/annrheumdis-2017-212534.
55. Mullington JM, et al. Developing biomarker arrays predicting sleep and circadian-coupled risks to health. Sleep. 2016; 39(4): 727-736.